Description
A BET bromodomain inhibitor; decreases c-Myc expression and induces cancer cell death in c-Myc-driven cancer cell lines in vitro; inhibits tumor growth in triple-negative breast, colorectal, and lung cancer patient-derived mouse xenograft models
Formal name: 3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-α,α-dimethyl-5-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-5H-pyrido[3,2-b]indole-7-methanol
Synonyms:
Molecular weight: 495.6
CAS: 1800340-40-2
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Chromatin Reader Interactions||Research Area|Cancer|Transcription Factors||Research Area|Epigenetics, Transcription, & Translation|Readers|Bromodomains
